Please login to the form below

Not currently logged in
Email:
Password:

JPA adds to Washington team

Jeff Goldfarb to join PR agency as VP
JPA Jeff Goldfarb

JPA Health Communications has expanded its Washingtom team with the appointment of Jeff Goldfarb as VP.

Goldfarb has two decades' experience in marketing, branding and communications, said JPA, with significant experience in the healthcare industry. He joins from Matthews Media Group (MMG).

As VP and senior strategist at MMG, Goldfarb developed communications plans and ran patient recruitment initiatives of clinical trials. He also managed public health communications programmes for the Food and Drug Administration and National Cancer Institute.

Before joining MMG, Goldfarb worked on marketing programmes for products such as Claritin and Glucophage. He previously worked for the agency Trahan, Burden, Charles where he managed marketing objectives for the likes of Blue Cross Blue Shield of Maryland and the Baltimore Ravens.

In his new role Goldfarb will 'lead several client projects, participate in new business efforts and support staff development', JPA told PMLiVE. He will support pharmaceutical clients and non-profit organisations, and will start out with a team of four.

“We are thrilled to welcome Jeff to the agency,” said Carrie Jones, principal and managing director of JPA. “His extensive communications experience in the healthcare industry will help us deliver the high-quality results our clients expect.”

30th January 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...

Infographics